7827 logo

HanchorBio Inc. Stock Price

TPEX:7827 Community·NT$16.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

7827 Share Price Performance

NT$130.00
84.00 (182.61%)
NT$130.00
84.00 (182.61%)
Price NT$130.00

7827 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with minimal risk.

1 Risk
0 Rewards

HanchorBio Inc. Key Details

NT$312.2m

Revenue

NT$0

Cost of Revenue

NT$312.2m

Gross Profit

NT$809.8m

Other Expenses

-NT$497.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-3.83
100.00%
-159.38%
8.6%
View Full Analysis

About 7827

Founded
2020
Employees
n/a
CEO
Shi-Kau Liu
WebsiteView website
www.hanchorbio.com

HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients. The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins. HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China.

Recent 7827 News & Updates

Recent updates

No updates